Anjali Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anjali Patel has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Soyeb Pathan
Research and Development Cell (RDC), Parul University, Vadodara 391760, India
18 shared publications - Nilesh Narkhede
Polyoxometalate and Catalysis Laboratory
13 shared publications Sukriti Singh
The Maharaja Sayajirao University of Baroda
10 shared publications- Anish Patel
Polyoxometalates and Catalysis Laboratory, Department of Chemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, India
9 shared publications Ketan Patel
Polyoxometalates and Catalysis Laboratory, Department of Chemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, India
8 shared publicationsMargi Joshi
7 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Elsevier in Next Sustainability
- Vol. 8
Undecaphosphotungstates anchored to Zeolite beta: Characterization and evaluation in levulinic and succinic acid for the synthesis of biofuel additives
- 1 October 2026
- Published by Elsevier in Next Sustainability
- Vol. 8
Open AccessUndecaphosphotungstates anchored to Zeolite beta: Characterization and evaluation in levulinic and succinic acid for the synthesis of biofuel additives
- Open Access
- 22 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (30) , 27960-27976
Anchored dilacunary phosphotungstates on zeolite HY: synthesis and solvent free selective oxidation of levulinic acid to succinic acid using environmentally benign oxidant, H 2 O 2
A redox-active lacunary polyoxometalate anchored to zeolite HY for selective transformation of levulinic acid to succinic acid.
- 22 May 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (30) , 27960-27976
Open AccessAnchored dilacunary phosphotungstates on zeolite HY: synthesis and solvent free selective oxidation of levulinic acid to succinic acid using environmentally benign oxidant, H 2 O 2
A redox-active lacunary polyoxometalate anchored to zeolite HY for selective transformation of levulinic acid to succinic acid.
- 21 April 2026
- Published by Royal Society of Chemistry (RSC) in Catalysis Science & Technology
- Vol. 16 (9) , 3236-3254
Redox–acid cooperative bifunctional catalysts comprising dilacunary phosphotungstates and zeolite Hβ for the synthesis of n -butyl levulinate and succinic acid
A newly engineered PW 10 /ZHβ catalyst achieves near-perfect control over biomass conversion, enabling highly selective esterification and a breakthrough 100% selective oxidation route to succinic acid, opening a new horizon in sustainable catalysis.
- 21 April 2026
- Published by Royal Society of Chemistry (RSC) in Catalysis Science & Technology
- Vol. 16 (9) , 3236-3254
Redox–acid cooperative bifunctional catalysts comprising dilacunary phosphotungstates and zeolite Hβ for the synthesis of n -butyl levulinate and succinic acid
A newly engineered PW 10 /ZHβ catalyst achieves near-perfect control over biomass conversion, enabling highly selective esterification and a breakthrough 100% selective oxidation route to succinic acid, opening a new horizon in sustainable catalysis.
- Open Access
- 7 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Pharmaceutics
- Vol. 3 (3) , 738-748
In vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracil
With the advent of nanotechnology, combined drug therapies employing dual-drug delivery provide an efficient way to overcome the drawbacks of conventional chemotherapy, such as lack of specificity, multidrug resistance and low aqueous solubility. Herein, a dual-drug delivery system based on mesoporous silica nanoparticles (MSNs) was developed to target tumours with the dual-responsive co-delivery of two anticancer drugs, camptothecin (CPT) and 5-fluorouracil (5-FU), in a sequential manner. The mesopores were loaded with CPT, and subsequently, a pegylated-biotin polymer was used to coat them. The disulphide link and acid group present in the polymer contribute to the stimuli-triggered release of the drugs. Since cancer cells need biotin to continue proliferating, it functions as a targeting ligand. Mathematical modelling studies revealed that the drug-release kinetics followed a diffusion mechanism for both the hydrophobic and hydrophilic drugs. Beyond in vitro release and cytotoxicity assays, extensive in vivo biological evaluations, including liver function markers, serum biochemistry and histopathological examinations, demonstrated pronounced tumour suppression with reduced hepatic toxicity. The nanocarrier downregulated key tumour biomarkers, effectively lowered serum transaminases and restored normal liver architecture. Collectively, these findings affirm the translational potential of this smart dual-drug delivery platform for cancer therapy.
- 7 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Pharmaceutics
- Vol. 3 (3) , 738-748
Open AccessIn vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracil
With the advent of nanotechnology, combined drug therapies employing dual-drug delivery provide an efficient way to overcome the drawbacks of conventional chemotherapy, such as lack of specificity, multidrug resistance and low aqueous solubility. Herein, a dual-drug delivery system based on mesoporous silica nanoparticles (MSNs) was developed to target tumours with the dual-responsive co-delivery of two anticancer drugs, camptothecin (CPT) and 5-fluorouracil (5-FU), in a sequential manner. The mesopores were loaded with CPT, and subsequently, a pegylated-biotin polymer was used to coat them. The disulphide link and acid group present in the polymer contribute to the stimuli-triggered release of the drugs. Since cancer cells need biotin to continue proliferating, it functions as a targeting ligand. Mathematical modelling studies revealed that the drug-release kinetics followed a diffusion mechanism for both the hydrophobic and hydrophilic drugs. Beyond in vitro release and cytotoxicity assays, extensive in vivo biological evaluations, including liver function markers, serum biochemistry and histopathological examinations, demonstrated pronounced tumour suppression with reduced hepatic toxicity. The nanocarrier downregulated key tumour biomarkers, effectively lowered serum transaminases and restored normal liver architecture. Collectively, these findings affirm the translational potential of this smart dual-drug delivery platform for cancer therapy.
- 12 February 2026
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 28 (9) , 4213-4224
Synthesis of next-generation biofuel additive, γ-valerolactone, via hydrogenation of levulinic acid in the presence of formic acid over nickel-exchanged 12-tungstophosphoric acid supported on neutral Al 2 O 3 and its kinetics study
In this study, an innovative approach was developed for the synthesis of γ-valerolactone (GVL), a highly versatile keto-lactone and a promising eco-friendly fuel additive. For that, a sustainable catalyst, nickel-exchanged 12-tungstophosphoric acid supported on neutral Al2O3, was synthesized and extensively characterized using EDX, NH3-TPD, BET, TGA, FT-IR, UV-Vis-NIR, XPS, 31P NMR, powder XRD, and TEM analyses. The catalytic activity was studied for the hydrogenation of levulinic acid using formic acid as an internal hydrogen source, which showcased its excellent performance by achieving 76% conversion and a high turnover number of 7451. Compared to existing research, 100% selectivity was demonstrated for GVL, a highly desired product, with an exceptionally high substrate-to-catalyst ratio of 4902. This not only emphasizes the efficiency of the catalyst but also highlights its superior catalytic activity and robust performance under mild reaction conditions, making it a more effective and sustainable option in comparison to previously reported catalysts. To determine the reaction order, detailed kinetic studies were conducted at various temperatures and over different reaction times (in hours). Additionally, this study presents the in situ reduction of Ni(II) to Ni(0), which was confirmed through X-ray photoelectron spectroscopy. The catalyst stability was established via a hot filtration test, and its reusability over multiple catalytic cycles confirmed its robust heterogeneous nature. This work highlights the catalyst potential in advancing sustainable and renewable energy solutions, making significant strides toward green and cost-effective processes.
- 12 February 2026
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 28 (9) , 4213-4224
Synthesis of next-generation biofuel additive, γ-valerolactone, via hydrogenation of levulinic acid in the presence of formic acid over nickel-exchanged 12-tungstophosphoric acid supported on neutral Al 2 O 3 and its kinetics study
In this study, an innovative approach was developed for the synthesis of γ-valerolactone (GVL), a highly versatile keto-lactone and a promising eco-friendly fuel additive. For that, a sustainable catalyst, nickel-exchanged 12-tungstophosphoric acid supported on neutral Al2O3, was synthesized and extensively characterized using EDX, NH3-TPD, BET, TGA, FT-IR, UV-Vis-NIR, XPS, 31P NMR, powder XRD, and TEM analyses. The catalytic activity was studied for the hydrogenation of levulinic acid using formic acid as an internal hydrogen source, which showcased its excellent performance by achieving 76% conversion and a high turnover number of 7451. Compared to existing research, 100% selectivity was demonstrated for GVL, a highly desired product, with an exceptionally high substrate-to-catalyst ratio of 4902. This not only emphasizes the efficiency of the catalyst but also highlights its superior catalytic activity and robust performance under mild reaction conditions, making it a more effective and sustainable option in comparison to previously reported catalysts. To determine the reaction order, detailed kinetic studies were conducted at various temperatures and over different reaction times (in hours). Additionally, this study presents the in situ reduction of Ni(II) to Ni(0), which was confirmed through X-ray photoelectron spectroscopy. The catalyst stability was established via a hot filtration test, and its reusability over multiple catalytic cycles confirmed its robust heterogeneous nature. This work highlights the catalyst potential in advancing sustainable and renewable energy solutions, making significant strides toward green and cost-effective processes.
- 28 January 2026
- Published by Royal Society of Chemistry (RSC) in Sustainable Energy & Fuels
- Vol. 10 (4) , 1108-1121
Upgrading the Brønsted acidity of zeolite Hβ via phosphotungstates: engineering a high-performance catalytic platform for the production of energy-efficient biofuel additives
A sustainable PW 12 /ZHβ catalytic route for mono- and diesterification towards efficient production of biofuel additives.
- 28 January 2026
- Published by Royal Society of Chemistry (RSC) in Sustainable Energy & Fuels
- Vol. 10 (4) , 1108-1121
Upgrading the Brønsted acidity of zeolite Hβ via phosphotungstates: engineering a high-performance catalytic platform for the production of energy-efficient biofuel additives
A sustainable PW 12 /ZHβ catalytic route for mono- and diesterification towards efficient production of biofuel additives.
- 22 October 2025
- Published by Springer Nature in Journal of Porous Materials
- Vol. 33 (1) , 231-247
Improving the bioavailability of alendronate sodium using SBA-15 and SBA-16 for osteoporosis and its cytotoxic behavior towards osteosarcoma
- 22 October 2025
- Published by Springer Nature in Journal of Porous Materials
- Vol. 33 (1) , 231-247
Improving the bioavailability of alendronate sodium using SBA-15 and SBA-16 for osteoporosis and its cytotoxic behavior towards osteosarcoma
- Open Access
- 25 September 2025
- Published by IntechOpen
Upgrading the Acidity of Zirconia via Merging with Dilacunary Phosphotungstates: Synthesis, Characterization and Production of Alkyl Levulinates
Zirconia-based materials have secured a prestigious position in the field of heterogeneous catalysis due to their exceptional thermal stability, tunable acidity and robust surface properties. Their synergy with heteropolyacids can be exemplified as “polishing the pearl”. This chapter elucidates upgrading the acidity of zirconia via the incipient wet impregnation method of dilacunary phosphotungstate and its characterization. The catalyst was examined in the esterification of levulinic acid with 1-butanol, which resulted in significant selectivity (>90%) of butyl levulinate and a high turnover number (1850) under mild reaction conditions. A kinetic study determined the activation energy and order of the reaction. The catalyst showcases its stability over multiple recycles, followed by its industrial relevance via successful scale-up trials. The versatility of the catalyst was also explored in the esterification of levulinic acid with bio-based alcohols, underscoring its broad applicability to alkyl levulinates, making this material a promising candidate for industrial applications.
- 25 September 2025
- Published by IntechOpen
Open AccessUpgrading the Acidity of Zirconia via Merging with Dilacunary Phosphotungstates: Synthesis, Characterization and Production of Alkyl Levulinates
Zirconia-based materials have secured a prestigious position in the field of heterogeneous catalysis due to their exceptional thermal stability, tunable acidity and robust surface properties. Their synergy with heteropolyacids can be exemplified as “polishing the pearl”. This chapter elucidates upgrading the acidity of zirconia via the incipient wet impregnation method of dilacunary phosphotungstate and its characterization. The catalyst was examined in the esterification of levulinic acid with 1-butanol, which resulted in significant selectivity (>90%) of butyl levulinate and a high turnover number (1850) under mild reaction conditions. A kinetic study determined the activation energy and order of the reaction. The catalyst showcases its stability over multiple recycles, followed by its industrial relevance via successful scale-up trials. The versatility of the catalyst was also explored in the esterification of levulinic acid with bio-based alcohols, underscoring its broad applicability to alkyl levulinates, making this material a promising candidate for industrial applications.
- Open Access
- 11 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (40) , 33657-33666
Engineered MCM-48 and heteropolyacid based hybrid nano-drug delivery systems for controlled release of metformin hydrochloride for diabetes mellitus treatment
In vitro dissolution of MTF/TPA/nMCM-48 was studied to overcome limitations of MTF. The release profile was compared with a marketed formulation and cytotoxicity was tested on a liver cancer cell line for anticancer potential.
- 11 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (40) , 33657-33666
Open AccessEngineered MCM-48 and heteropolyacid based hybrid nano-drug delivery systems for controlled release of metformin hydrochloride for diabetes mellitus treatment
In vitro dissolution of MTF/TPA/nMCM-48 was studied to overcome limitations of MTF. The release profile was compared with a marketed formulation and cytotoxicity was tested on a liver cancer cell line for anticancer potential.